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 Abstract
Aim: To assess the correlation between homocysteine concentrations and gestational age, gender, Apgar score, 
complications in pregnancy, delivery modalities and levels of vitamin B12 and foliate.
Material and methods: Concentration of homocysteine, vitamins-B12, foliate were measured in cord blood and 
mother blood. There were 40 full term babies and 38 preterm babies and their mothers.
Result: The homocysteine concentration in newborns correlated with homocysteine level in mothers. There was 
no difference in homocysteine level regardless of newborn’s gender. 
There was no correlation in the homocysteine concentration of mother’s blood and  cord blood with the levels of 
vitamin B12 and foliate.
In full term newborns a significant increase in homocysteine levels in comparison with premature babies was 
observed (7.2±1.4µmol/l vs. 6.4±1.3µmol/l; p=0.01). Additionally, negative correlation between the mothers’ age 
and homocysteine concentration (r=-0.23; p=0.04) and positive correlation between homocysteine concentration 
in cord plasma and gestation age (r=0.28; p=0.01) were found.
Conclusion: Homocysteine concentration depends on gestational age, Apgar score and mother’s age. There 
is no correlation between homocysteine level and hypertension during pregnancy, type of delivery, levels of 
vitamin B12 and foliate. Determination of homocysteine level is therefore of no significant importance in newborns 
pathophysiology.
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Introduction
Homocysteine	 is	 derived	 from	 the	 essential	 amino	 acid	
methionine	 and	 its	 metabolism	 depends	 on	 the	 B	 vitamins-
cobalamin	(vitamin	B12),	pyridoxine	(vitamin	B6),	and	folic	acid	
[1].	 Previous	 studies	 have	 shown	 that	 hyperhomocysteinemia	
is	 an	 independent	 risk	 factor	 of	 premature	 disease,	 stroke,	
coronary	artery	disease	and	venous	thromboembolism,	as	well	as	
neuropsychiatric	diseases	[2].
The	mechanism	of	the	damaging	effect	of	homocysteine	is	
very	complex	and	not	completely	explained.	It	has	been	proven	
that	homocysteine	particles	directly	damage	the	endothelium	in	
vessels;	they	intensify	the	oxidation	of	low	density	lipoproteins	
(LDL)	and	 they	 increase	 the	aggregation	of	platelets	 [3].	They	
also	 stimulate	 the	 proliferation	 of	 	 smooth	 muscles	 in	 blood	
vessels	and	intensify	oxidation	stress.	It	has	recently	been	proven	
that	 homocysteine	 can	 cause	 damage	 to	 collagen	 structures	 in	
blood	 vessels	 and	 destroy	 DNA	 cells,	 which	 leads	 directly	 to	
dysfunction	or	even	the	death	of	the	endothelium	[4,	5].
The	aim	of	the	study	was	to	assess	the	correlation	between	
homocysteine	concentrations	and	gestational	age,	gender,	Apgar	
score,	complications	in	pregnancy,	delivery	modalities	and		levels	
of	Vitamin	B12	and	foliate.
Material and methods
The	protocol	was	approved	by	ethics	committee	at	Silesian	
Medical	University,	Poland.
This	prospective	study	included	78	pregnant	women	and	their	
fetuses	that	were	monitored	from	January,	2008	until	December,	
2008.	There	were	38	preterm	babies	and	40	full	term	babies.	
Maternal	 blood	 samples	 were	 collected	 via	 venipuncture	
at	the	time	of	admission	for	delivery.	Umbilical	cord	blood	was	
collected	by	direct	venipuncture	of	 the	umbilical	vein	after	 the	
delivery	 of	 the	 fetus	 before	 the	 passage	 of	 placenta.	All	 blood	
samples	were	collected	in	5ml	EDTA	tubes.	
Samples	 were	 centrifuged	 at	 3000	 r.p.m	 for	 10	 minutes.	
Plasma	was	extracted,	frozen	and	maintained	at	-70°.
Homocysteine	 concentrations	 of	 maternal	 and	 umbilical	
plasma	 were	 measured	 using	 MEIA	 methods	 (Abbott,	 USA)	
with	the	laboratory	reference	values	4.45-12.42µmol/l	and	whose	
production	norm	is	9.68	µmol/l.
The	 concentrations	 of	 vitamin	 B12	 and	 folic	 acid	 were	
measured	using	MEIA	methods	(Abbott,	USA).	The	laboratory	
reference	value	for	vitamin	B12	concentration	was	160-800	pg/
ml	and	for	foliate	5.3-14.4ng/ml.
The	study	protocol	was	approved	by	the	Ethics	Committee	
at	the	Medical	University	of	Silesia	and	all	participants	gave	their	
written	informed	consent.	During	pregnancy	all	women	had	been	
regularly	prescribed	a	daily	dose	of	vitamins	containing	0.8	mg	
of	folic	acid,	4	µg	of	vitamin	B12	and	2.6mg	of	vitamin	B6.
Statistical methods
Quantitative	variables	are	expressed	as	the	arithmetic	means	
with	 standard	 deviation	 (normally	 distributed	 variables)	 or	 as	
medians	with	interquartile	range	(those	not	normally	distributed).	
Categorical	variables	are	presented	as	crude	values.	
Data	 were	 tested	 for	 normality	 with	 the	 Shapiro-Wilk	W	
test.	The	analysis	was	performed	in	two	stages.	The	first	stage	of	
simple	 bivariate	 analysis	 included	 between-group	 comparisons	
and	the	assessment	of	the	relationship	between	variables.	
Associations	between	quantitative	variables	were	assessed	on	
the	basis	of	Pearson’s	or	Spearman	rank	correlation	coefficients.	
Between-group	differences	were	tested	using	the	Student	t-test	or	
the	Mann-Whitney	U	test	as	appropriate.	
For	 qualitative	 variables	 chi-squared	 or	 Fisher	 exact	 tests	
were	used.	P<0.05	was	considered	statistically	significant.	
Results
Characteristics	 of	 examined	 patients	 with	 the	 distinction	
between	newborns’	gender,	is	presented	in	Table	I.
Boys	had	a	 statistically	higher	birth	weight	 in	 comparison	
with	girls	(p=0.003).	
 Streszczenie
Cel pracy: Wykazanie, czy istnieje korelacja pomiędzy stężeniem homocysteiny a wiekiem płodowym, płcią, stanem 
ogólnym noworodków ocenianym w skali Apgar, problemami w ciąży, rodzajem porodu i stężeniem witaminy B12 
i kwasu foliowego.
Materiał i metody: Badano stężenie homocysteiny, witaminy B12, kwasu foliowego w surowicy krwi pępowinowej 
i w krwi matek. Noworodków donoszonych było 40, a wcześniaków 38. 
Wyniki: Stężenie homocysteiny u dziecka korelowało ze stężeniem homocysteiny u matki. Nie stwierdzono różnic 
istotnych statystycznie w stężeniu homocysteiny u noworodków w zależności od płci dziecka. Nie wykazano korelacji 
stężenia homocysteiny zarówno u matki jak i w krwi pępowinowej ze stężeniem witaminy B12 i kwasu foliowego. 
Wykazano istotnie wyższe stężenia homocysteiny u noworodków urodzonych w terminie porodu w porównaniu 
z noworodkami urodzonymi przedwcześnie (7,2±1,4µmol/l vs. 6,4±1,3µmol/l (p=0,01). Stwierdzono ujemną 
korelację pomiędzy wiekiem matki i stężeniem homocysteiny (r=-0,23; p=0,04) i dodatnią korelację pomiędzy 
stężeniem homocysteiny w krwi pępowinowej i wiekiem płodowym (r=0,28; p=0,01).
Wnioski: Stężenie homocysteiny w krwi pępowinowej  zależy od wieku płodowego, stanu po urodzeniu wg Apgar 
i wieku matki. Stężenie homocysteiny w krwi pępowinowej nie koreluje z nadciśnieniem w czasie ciąży u matki, 
rodzajem porodu, ani też nie zależy od stężenia witaminy B12 i kwasu foliowego. Oznaczanie stężenia homocysteiny 
w krwi pępowinowej nie stanowi użytecznego wskaźnika w patofizjologii noworodka.
 Słowa kluczowe: homocysteina / noworodek donoszony / wcześniak /  
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Table I. Characteristics of the examined groups in relation to gender of newborns. 
Table II. Homocysteine, vitamin B12 and foliate levels in maternal plasma and umbilical cord plasma in relation to gender of newborns. 
Table III. Factors determining homocysteine concentrations in newborns and mothers. 
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There	were	 no	 statistically	 significant	 differences	 between	
boys	and	girls	regarding		the	gestational	age,	number	of	pregnancy,	
single	or	multiple	pregnancy,	the	state	of	newborns	according	to	
Apgar	score	in	the	1st	minute	after	delivery	were	found.	Table	II	
presents	the	concentration	of	homocysteine,	B12	vitamin,	foliate	
in	mother’s	blood	and	their	newborns	blood.
The	 concentration	 of	 homocysteine	 in	 mothers’	 blood	
correlated	 with	 the	 value	 in	 umbilical	 cord	 blood	 (r=0.86	
p<0.0001).	(Figure	1).	
This	 relationship	 was	 observed	 in	 term	 newborns	 as	 well	
as	in	preterm	newborns.	(r=0.88,	p<0.001	and	r=0.82,	p<0.001,	
respectively).	
There	 were	 no	 statistically	 significant	 differences	 in	 the	
homocysteine	 concentration	 in	 newborns	 with	 the	 distinction	
between	the	newborns’	gender.	(Table	III).	
There	was	a	significantly	higher	homocysteine	concentration	
in	term	newborns	in	comparison	with	preterm	newborns	(7.2±1.4	
µmol/lvs.	6.4±	1.3µmol/l;	p=0.01)	but	those	differences	were	not	
found	 in	 homocysteine	 concentrations	 in	mothers	 of	 term	 and	
preterm	newborns.	(Table	III).	
Mothers	and	babies	born	by	natural	labour		had	a	significantly	
higher	homocysteine	concentration	in	comparison	with	mothers	
and	newborns	delivered	by	elective	Caesarean	section	(p<0.001).	
(Table	III).	
It	 was	 observed	 that	 newborns	 in	 good	 condition	 had	 a	
significantly	 higher	 homocysteine	 concentration	 in	 comparison	
with	 newborns	 delivered	 	 in	 a	 moderate	 or	 critical	 condition	
(p=0.04).	(Table	III).
Hypertension	 during	 pregnancy	 did	 not	 affect	 the	
concentration	 of	 homocysteine	 in	 either	 the	mother’s	 blood	 or	
umbilical	cord	blood.	(Table	III).
The	 concentration	 of	 vitamin	 B12	 and	 foliate	 levels	 in	
mother’s	 blood	 correlated	with	 the	 concentrations	 in	 umbilical	
cord	blood	(r=0.44;	p<0.01-	Vit	B12;	r=	0.58;	p<0.01-	foliate)	in	
all	examined	patients.	(Table	IV).
There	was	no	correlation	in	the	homocysteine	concentration	
of	mother’s	 blood	 and	umbilical	 cord	 blood	with	 the	 levels	 of	
vitamin	B12	and	foliate.	(Table	IV).
We	 observed	 a	 positive	 correlation	 between	 fetal	 age	 and	
the	homocysteine	concentration	in	umbilical	cord	blood	(r=0.28;	
p=0.01).	(Figure	2),	and	negative	correlation	between	the	mother’s	
age	and	the	homocysteine	level	in	umbilical	cord	blood	(r=-0.23;	
p=0.04).	(Figure	3).
Discussion
The	 concentration	 of	 homocysteine	 in	 pregnant	 women	
decreases	 in	 the	first	 trimester	of	gestation	 in	comparison	with	
women	who	are	not	pregnant.	Then	it	increases	and	reaches	the	
highest	level	in	the	third	trimester	of	gestation	[6].
The	pregnant	women,	who	participated	in	our	observations,	
had	a	mean	concentration	of	homocysteine	8.3±1.6µmol/l.	Those	
levels	are	the	accepted	norms.	The	concentration	of	homocysteine	
in	 all	 examined	 newborns	 showed	 levels	 within	 the	 accepted	
norms	 for	 adults	 and	was	 6.8±1.4µmol/l.	A	 significant	 relation	
between	the	concentration	of	homocysteine	in	the	cord	blood	and	
the	gestation	age	was	observed	by	Hongsprabhas	[7]. 
Also	 in	 our	 study	 the	 concentration	 of	 homocysteine	
was	 higher	 in	 term	 newborns	 (7.2±1.4µmol)	 than	 in	 preterm	
newborns	(6.4±1.3µmol)	(p=0.01). However	those	differences	in	
homocysteine	levels	could	arise	from	mode	of	delivery	because	
term	 newborns	 were	 delivered	 both	 by	 Cesarean	 section	 and	
natural,	 but	 preterm	 newborns	 only	 by	 Cesarean	 section.	 It	 is	
confirmed	 by	 our	 further	 observations	 in	 which	 we	 showed	
that	 there	 were	 no	 differences	 in	 homocysteine	 concentration	
between	 term	 and	 preterm	 infants	 born	 by	 Cesarean	 section.	
We	also	observed no	significant	differences	in	concentrations	of	
homocysteine	in	the	mother’s	blood	in	both	groups.	Concentration	
of	 homocysteine	 in	mothers	who	delivered	 at	 term	was	higher	
that	 in	 mothers	 who	 had	 preterm	 deliveries.	 Presumably	 the	
increasing	concentration	of	homocysteine	affects	the	spontaneous	
gestational	uterus	contractions	[8].	Our	study	shows	that	newborns	
born	by	natural	 labour	had	a	 significantly	higher	concentration	
of	homocysteine	than	the	newborns	born	by	elective	Caesarean	
section.	 There	 is	 a	 possibility	 that	 this	 is	 connected	 with	 the	
higher	concentration	of	cortisol,	which	increases	due	to	the	stress	
labor.	Umbilical	cord	plasma	homocysteine	levels	correlate	with	
the	corresponding	maternal	plasma	levels.	The	results	suggested	
fetal	 and	 neonatal	 metabolic	 adaptation	 to	 peri-partal	 events.	
It	 is	 known	 that	 a	 patient	 with	 Cushing’s	 syndrome,	 which	
is	 characterized	 by	 abnormally	 high	 serum	 concentrations	 of	
cortisol,	 also	have	hyperhomocysteinemia,	which	 suggests	 that	
high	serum	homocysteine	levels	are	a	consequence	of	high	serum	
cortisol	levels	[9].
Different	results	were	presented	by	Zanardo	et	al.	[10].	Their	
studies	showed	that	 the	concentration	of	homocysteine,	both	in	
the	mother’s	and	cord	blood,	was	higher	in	mothers	delivering	by	
Caesarean	section	in	comparison	with	natural	labor.	
Table IV. Results of analysis of linear correlation. 
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Researchers	 suggested	 that	 hyperhomocysteinemia	 in	
elective	 Caesarean	 section	 using	 nitrous	 general	 anesthesia	
may	 be	 related	 to	 iatrogenic	 hormonal	 and/or	 pharmacological	
metabolic	disturbances	at	the	time	of	delivery.
Our	 study	 did	 not	 show	 a	 correlation	 between	 the	
concentration	of	homocysteine,	folic	acid	and	vitamin	B12.	This	
may	result	from	the	fact	that	the	pregnant	women,	who	participated	
in	 the	 observation,	 took	 these	 vitamins.	 There	 is	 an	 evident	
relation	between	the	presence	of	folic	acid,	vitamin	B12	and	the	
concentration	 of	 homocysteine	 regardless	 of	 the	 mother’s	 age	
[11].	Research	done	by	Thomas	et	al.	on	a	group	of	12-13	year-old	
teenagers	showed	 that	 the	concentration	of	homocysteine,	both	
in	boys	and	girls,	was	significantly	related	to	 the	concentration	
of	 folic	 acid,	 it	was	 further	 observed	 that	 the	 concentration	 of	
homocysteine	 >or=8.5µmol	was	 related	 to	 a	 greater	 chance	 of	
the	occurrence	of	cardiovascular	diseases	in		families	[12].	In	our	
study	 there	were	no	differences	 in	homocysteine	 concentration	
between	boys	and	girls.	But	examinations	of	adults	showed	that	the	
concentration	of	homocysteine	is	higher	in	men	by	approximately	
2	µmol	in	comparison	with	women	[13].	This	difference	is	also	
present	in	the	group	of	teenagers	though	not	as	significant	as	in	
adults	 [14].	This	 lack	 of	 differences	 in	 homocysteine	 levels	 in	
newborns	suggests	that	the	concentration	of	homocysteine	related	
to	 the	 sex	becomes	present	with	 age,	which	may	be	 related	 to	
growing	muscles	depending	on	sex	and	age.
We	 also	 did	 not	 observe	 any	 differences	 in	 homocysteine	
concentration	according	as	newborns	condition.
A	 high	 concentration	 of	 homocysteine,	 higher	 than	 the	
accepted	 norms	 were	 observed	 in	 mothers	 who	 had	 different	
complications	during	pregnancy	i.e.	detachment	of	the	placenta,	
infarct	of	the	placenta,	PROM	(premature	rupture	of	membranes)	
and	preeclampsia	[15,	16].	
Our	study	did	not	confirm	those	observations.	Mothers	with	
hypertension	did	not	have	higher	concentration	of	homocysteine.	
El	 Khairy	 et	 al.	 also	 observed	 that	 high	 concentration	 of	
homocysteine	is	not	a	risk	factor	of	hypertension	in	pregnancy,	
pre-eclamptic	 state	 and	 pre-term	 delivery	 [17].	 However,	 the	
researchers	 analysed	 the	 relation	 between	 the	 concentration	 of	
cysteine	 and	 homocysteine.	 It	 was	 found	 that	 the	 higher	 risk	
of	the	above	mentioned	complications	is	observed	when	a	high	
concentration	of	cysteine	and	low	concentration	of	homocysteine	
is	present,	and	also	when	there	is	a	higher	concentration	of	both	
cysteine	and	homocysteine.	
A	 high	 concentration	 of	 homocysteine	 can	 result	 from	 its	
defective	excretion	by	a	pregnant	woman’s	kidneys	[18].	Other	
researchers	 suggest	 that	 a	 high	 concentration	 of	 homocysteine	
can	 induce	 the	 weakening	 of	 the	 collagen	 structure	 through	
damaging	transversal	bindings	which	then	leads	to	a	weakening	
of	 connective	 tissue	 [19,	 20].	 This	 process	 can	 induce	 the	
preterm	rupture	of	fetal	membranes	and	cause	preterm	delivery.	
According	 to	Kramer	et	 al.	 a	high	homocysteine	concentration	
may	 cause	 or	 be	 a	marker	 for	 placental	 vascular	 changes	 that	
stimulate	 hormonal,	 inflammatory	 or	 cellular	 changes	 that	
initiate	 or	 accelerate	 the	 cascade	 of	 events	 leading	 to	 preterm	
labor	or	PROM	[21].	A	high	plasma	homocysteine	concentration	
may	 act	 through	 a	 direct	mechanism,	 however	 in	 vitro	 studies	
have	 reported	 that	 homocysteine	 increased	 the	 frequency	 of	
spontaneous	 contractions	 of	 a	 pregnant	 woman’s	myometrium	
suspended	in	an	organ	bath.
 
Figure 1. Correlation between mother’s and child’s homocysteine concentrations. 
 
Figure 2. Correlation between gestational age and child’s homocysteine 
concentrations. 
 
Figure 3. Correlation between mother’s age and child’s homocysteine 
concentrations.
Nr 10/2011766
P R A C E  O R Y G I N A L N E
  n e onato l og ia
Baumert M, et al.
Ginekol Pol. 2011, 82, 761-766 
We	 conclude	 that	 determination	 of	 homocysteine	 level	
is	 of	 no	 significant	 importance	 in	 newborns	 pathophysiology.	
Homocysteine	level	depends	on	gestational	age,	Apgar	score	and	
mother’s	age.	But	there	is	no	correlation	between	homocysteine	
level	and	hypertension	during	pregnancy,	type	of	delivery,	levels	
of	vitamin	B12	and	foliates.	
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